Bristol-Myers Squibb
BMY
2,293 hedge funds and large institutions have $76.5B invested in Bristol-Myers Squibb in 2025 Q2 according to their latest regulatory filings, with 151 funds opening new positions, 822 increasing their positions, 1,032 reducing their positions, and 309 closing their positions.
0.5% more ownership
Funds ownership: 80.3% → 80.8% (+0.5%)
7% less funds holding
Funds holding: 2,478 → 2,293 (-185)
12% less call options, than puts
Call options by funds: $1.12B | Put options by funds: $1.26B
20% less repeat investments, than reductions
Existing positions increased: 822 | Existing positions reduced: 1,032
23% less capital invested
Capital invested by funds: $99.6B → $76.5B (-$23B)
51% less first-time investments, than exits
New positions opened: 151 | Existing positions closed: 309
57% less funds holding in top 10
Funds holding in top 10: 37 → 16 (-21)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$533M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$500M |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$479M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$450M |
| 5 |
Man Group
London,
United Kingdom
|
+$270M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$553M |
| 2 |
GQG Partners
Ft. Lauderdale,
Florida
|
-$442M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$383M |
| 4 |
Bank of New York Mellon
New York
|
-$295M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$265M |
BMY Hedge Fund Activity: Q2 2025 in Review
2,293 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb (BMY) for Q2 2025, worth a combined $76.5B — down 23% from $99.6B a quarter earlier.
Sellers outnumbered buyers: 309 funds closed out of BMY and 151 opened new positions — a net loss of 158 holders — while 1,032 trimmed existing stakes and 822 added.
The largest buyer was BlackRock, adding an estimated $533M. The largest seller was DZ Bank, cutting an estimated $553M.
- 2,293 institutional investors held Bristol-Myers Squibb (BMY) as of Q2 2025, down from 2,478 in Q1 2025.
- Funds reported $76.5B of Bristol-Myers Squibb stock for Q2 2025, down 23% quarter-over-quarter.
- 151 funds opened new Bristol-Myers Squibb positions in Q2 2025 and 309 closed out, a net change of -158 holders.
- The largest Bristol-Myers Squibb buyer in Q2 2025 was BlackRock, an estimated $533M added.
- The largest Bristol-Myers Squibb seller in Q2 2025 was DZ Bank, an estimated $553M sold.
Based on aggregated 13F filings for Q2 2025.